InterCure Ltd.
INCR · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $65,006 | $65,006 | $56,556 | $56,556 |
| % Growth | 0% | 14.9% | 0% | – |
| Cost of Goods Sold | $44,894 | $44,894 | $56,361 | $56,361 |
| Gross Profit | $20,112 | $20,112 | $196 | $196 |
| % Margin | 30.9% | 30.9% | 0.3% | 0.3% |
| R&D Expenses | $96 | $96 | $98 | $98 |
| G&A Expenses | $7,151 | $7,151 | $17,648 | $17,648 |
| SG&A Expenses | $20,651 | $20,651 | $31,831 | $31,831 |
| Sales & Mktg Exp. | $13,058 | $13,058 | $13,386 | $13,386 |
| Other Operating Expenses | -$3,493 | -$3,493 | $7,128 | $7,128 |
| Operating Expenses | $17,254 | $17,254 | $39,056 | $39,056 |
| Operating Income | $2,858 | $2,858 | -$38,860 | -$38,860 |
| % Margin | 4.4% | 4.4% | -68.7% | -68.7% |
| Other Income/Exp. Net | $0 | $0 | -$5,538 | -$5,538 |
| Pre-Tax Income | -$1,149 | -$1,149 | -$44,398 | -$44,398 |
| Tax Expense | $243 | $243 | -$8,005 | -$8,005 |
| Net Income | -$852 | -$852 | -$34,614 | -$34,614 |
| % Margin | -1.3% | -1.3% | -61.2% | -61.2% |
| EPS | -0.015 | -0.015 | -0.79 | -0.79 |
| % Growth | 0% | 98.1% | 0% | – |
| EPS Diluted | -0.015 | -0.015 | -0.79 | -0.79 |
| Weighted Avg Shares Out | 56,800 | 56,800 | 43,914 | 43,914 |
| Weighted Avg Shares Out Dil | 56,800 | 56,800 | 43,972 | 43,972 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $4,453 | $4,453 |
| Depreciation & Amortization | $4,226 | $4,226 | $2,417 | $2,046 |
| EBITDA | $7,125 | $7,125 | -$46,683 | -$47,054 |
| % Margin | 11% | 11% | -82.5% | -83.2% |